Intech Investment Management LLC Buys 52,306 Shares of Humana Inc. (NYSE:HUM)

Intech Investment Management LLC grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 84.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 114,209 shares of the insurance provider's stock after buying an additional 52,306 shares during the period. Intech Investment Management LLC owned approximately 0.09% of Humana worth $36,175,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV boosted its holdings in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock worth $27,000 after buying an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. lifted its holdings in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. bought a new position in shares of Humana during the 3rd quarter valued at about $29,000. Ashton Thomas Securities LLC bought a new position in shares of Humana during the 3rd quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP lifted its holdings in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Up 5.8 %

HUM stock opened at $294.02 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $35.40 billion, a PE ratio of 26.04, a PEG ratio of 2.19 and a beta of 0.52. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18. The business's 50 day simple moving average is $277.86 and its 200 day simple moving average is $331.03.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. As a group, research analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date is Tuesday, December 31st. Humana's dividend payout ratio is 31.36%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Wells Fargo & Company cut their price objective on Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a report on Monday, November 4th. Truist Financial cut their target price on Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a research note on Friday, October 11th. Sanford C. Bernstein upgraded Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price on the stock in a research note on Tuesday, October 8th. JPMorgan Chase & Co. boosted their target price on Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research note on Wednesday, August 21st. Finally, KeyCorp started coverage on Humana in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.